DrugDashboards

Erythromycin

Erythromycin · ERYTHROMYCIN 250 mg/1 · Tablet, Film Coated · Oral · Alembic Pharmaceuticals Inc.

NDC 62332-0397-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for erythromycin (oral solid) in the next 90 days

sole-source market · 2 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA215661
TE code
AB
Approval date
Aug 24, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Erythromycin (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Teva Pharmaceuticals USA, Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.ERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Arbor Pharmaceuticals, Inc.ERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Arbor Pharmaceuticals, Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Orange Pharmaceuticals USA LLCERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Orange Pharmaceuticals USA LLCERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Wilshire PharmaceuticalsERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Wilshire PharmaceuticalsERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ERYTHROMYCIN 500 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.ERYTHROMYCIN 500 mg/1Jul 15, 2026Aug 28, 2026
Nivagen Pharmaceuticals, Inc.ERYTHROMYCIN 500 mg/1Jul 15, 2026Aug 26, 2026
Nivagen Pharmaceuticals, Inc.ERYTHROMYCIN 250 mg/1Jul 15, 2026Aug 26, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Erythromycin — NDC 62332-0397-30," retrieved September 3, 2026, https://drugdashboards.com/drug/62332039730.

Free to cite with attribution — see how the data is put together.